You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Coronary Artery Disease

The PMC reviewed relevant performance measures and makes the following recommendations.

November 2018 printable version of recommendations.
Printable version of the recommendations.

ACP supports this measure.

ID# MIPS 118
NQF 0066

More Information

Angiotensisn Converting Enzyme-Inhibitor (ACE-I) or Angiotensisn Receptor Blocker (ARB) Therapy--Diabetes of LVSD (LVEF <40%)

Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy. 
Date Reviewed: November 4, 2018

ACP supports this measure.

ID# QPP 006
ID# NQF 0067

More Information

Chronic Stable Coronary Artery Disease: Antiplatelet Therapy

 Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12 month period who were prescribed aspirin or clopidogrel.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# QPP 007
ID# NQF 0070

More Information

Coronary Artery Disease: Beta Blocker Therapy - Prior Myocardial Infarction or Left Ventricular Systolic Dysfunction (LVEF <40%)

Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have a prior myocardial infarction or a current or prior LVEF <40% who were prescribed beta-blocker therapy.
Date Reviewed: November 19, 2017